PAH Gene (Phenylalanine Hydroxylase): Function, Mutations, and Associated Diseases

Comprehensive biomedical overview of the PAH gene, including genomic context, expression, pathogenic variants, and clinical significance in phenylketonuria.

Gene Information Card

Symbol PAH
Full Name Phenylalanine hydroxylase
Gene Type protein-coding
Chromosomal Location 12q23.2
NCBI Gene ID 5053 ncbi.nlm.nih.gov/gene/5053
Ensembl ID ENSG00000171759
UniProt ID P00439
OMIM ID 612349
HGNC ID 8582
Aliases PKU, phenylalanine-4-hydroxylase

Description

The PAH gene encodes phenylalanine hydroxylase, an enzyme that catalyzes the conversion of L-phenylalanine to L-tyrosine using tetrahydrobiopterin (BH4) and molecular oxygen as cofactors. This reaction is the rate-limiting step in the catabolism of phenylalanine. Mutations in PAH lead to phenylketonuria (PKU) and other forms of hyperphenylalaninemia, characterized by elevated phenylalanine levels in blood and tissues, which can cause intellectual disability if untreated. The enzyme is primarily expressed in the liver and kidney.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Phenylketonuria (PKU) Loss-of-function mutations in PAH reduce or abolish enzyme activity, leading to accumulation of phenylalanine and its metabolites, causing neurotoxicity. ClinVar, OMIM
Hyperphenylalaninemia, non-PKU Milder mutations cause partial enzyme deficiency, resulting in moderate elevation of phenylalanine without severe clinical phenotype. ClinVar, OMIM
Maternal phenylketonuria Mutations in the mother cause elevated phenylalanine during pregnancy, leading to fetal developmental abnormalities. OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Liver High (nTPM ~ 200) Primary site of expression
Kidney Moderate (nTPM ~ 20) Secondary expression
Brain Low (nTPM < 1) Minimal expression
Small intestine Low (nTPM < 1) Trace expression
Cell Line Expression
Cell Line nTPM Notes
HepG2 (liver carcinoma) High Used as model for hepatic expression
HEK293 (embryonic kidney) Moderate Transfected for functional studies
HeLa (cervical carcinoma) Low Not endogenously expressed
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1222C>T (p.Arg408Trp) Missense Common (allele frequency ~10-20% in PKU) Severe enzyme deficiency, classic PKU
c.782G>A (p.Arg261Gln) Missense Common (allele frequency ~5-10%) Moderate to severe deficiency
c.842C>T (p.Pro281Leu) Missense Common (allele frequency ~5%) Variable severity, often mild
c.1066-11G>A (IVS10-11G>A) Splicing Common (allele frequency ~5%) Splicing defect, severe phenotype
c.168+5G>T (IVS2+5G>T) Splicing Less common Splicing defect, severe
Mutation functional classification

Loss of Function (LOF)

Most PAH mutations are loss-of-function, reducing or eliminating enzyme activity. This leads to phenylalanine accumulation and PKU.

Gain of Function (GOF)

No gain-of-function mutations have been reported for PAH.

Dominant Negative (DN)

PAH is a homotetramer; some missense mutations may exert a dominant-negative effect by disrupting tetramer assembly, but this is rare and not well established.

Pathways

Phenylalanine metabolism (KEGG: hsa00360)
Tyrosine metabolism (KEGG: hsa00350)
Tetrahydrobiopterin (BH4) metabolism

Protein Summary

Phenylalanine hydroxylase (PAH) is a homotetrameric enzyme, each subunit containing a catalytic domain and a regulatory domain. It requires iron and tetrahydrobiopterin (BH4) as cofactors. The enzyme is allosterically regulated by phenylalanine and inhibited by its cofactor BH4. Deficiency leads to PKU, treatable by dietary restriction of phenylalanine and BH4 supplementation in some cases.

Related Products

Product name Cat.No. Species Gene ID
PAH Knockout HEK293 Cell Line EDJ-KQ3979 Human 5053 Details Get a Quote
PAH Knockout HeLa Cell Line EDJ-KQ54074 Human 5053 Details Get a Quote
PAH Knockout A-549 Cell Line EDJ-KQ62562 Human 5053 Details Get a Quote
PAH Knockout HCT 116 Cell Line EDJ-KQ71032 Human 5053 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: